Iproteos has been a semi-finalist in the II Award for the Best Entrepreneurial Biotechnology Project, a technology transfer prize given by the Spanish Society of Biochemistry (Sociedad Española de Bioquímica (SEBBM)). The spin-off, which is promoted by IRB Barcelona –located at the Barcelona Science Park- and the University of Barcelona –through the Bosch y Gimpera Foundation, also at the Park – was founded in June with the mission to develop and commercialize a new generation of more efficient low cost drugs with fewer side effects.

More information: Barcelona Science Park (Parc Científic de Barcelona (PCB)